About this trial
This study aims to evaluate the potential effects of mesenchymal stem cell-derived suspended exosome therapy on facial skin quality using objective imaging analysis. Thirty adult participants will receive intradermal exosome applications in three treatment sessions performed at one-month intervals. Facial skin analysis will be conducted using the VISIA imaging system before each treatment session and six months after the final treatment. The study will examine changes in multiple facial skin characteristics including wrinkles, pigmentation, skin texture, pores, UV spots, red areas, brown spots, and porphyrins to determine whether exosome therapy may improve overall facial skin quality.
Eligibility criteria
Qualifiers
• Adults aged 18 to 65 years
Individuals presenting facial skin aging signs
Willingness to undergo three intradermal treatment sessions
Ability to comply with study visits and follow-up assessments
Disqualifiers
Pregnancy or breastfeeding
Active skin infection, inflammatory skin disease, or open wounds in the treatment area
History of allergic reactions to injectable dermatologic treatments
Use of systemic or topical retinoids within the past 6 months
Trial design
Treatments tested in this trial
- Mesenchymal Stem Cell-Derived Exosome
Treatment groups
Locations
Sponsors and collaborators
Mert Ersan
Lead sponsor
Yeditepe University Hospital
Sponsor institution